In honor of Higher Education Day, celebrate FIU’s earning its latest Carnegie recognition — and meet recent alumni who are ...

Eli Lilly (NYSE: LLY) sells a broad range of medicines, from cancer and immunology drugs to treatments for migraine. Right ...

Although as of this week the stock has declined by more than 4% since the start of the year, there's little reason to believe ...

Camurus licensed its FluidCrystal drug delivery tech to Eli Lilly for global development of long-acting incretin therapies ...

Eli Lilly is counting on Camurus and its long-acting delivery technology to help take its portfolio of obesity and diabetes drugs to the next level with a licensing deal worth up to $870 million.

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, ...

Eli Lilly has spent the last several years reintroducing ... call for “applicants” alongside the URL for the company’s careers hub. The very public hiring drive puts Lilly in contrast ...

First of all, the world record-holder, Lilly King, was swimming the final race of her career on U.S. soil. The Olympic gold ...

After 16 years at the helm of one of Richmond's premier high school football programs, former University of Richmond star ...

INDIANAPOLIS, May 8, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE ... Lilly's executive committee. A 16-year Lilly veteran, Custer began his career at Lilly in sales and marketing before ...

Glamour’ chatted with the psychologist and perinatal mental-health specialist about how she’s choosing to use her voice after ...

Eli Lilly said yesterday that it will acquire SiteOne Therapeutics, a biotech developing non-opioid pain drugs, for up to $1 ...